Journal for ImmunoTherapy of Cancer
ISSN: 2051-1426
Publisher: BioMed Central
Publications (51)
Electrocardiographic features of immune checkpoint inhibitor associated myocarditis (2021)
Zlotoff DA, Hassan MZ, Zafar A, Alvi RM, Awadalla M, Mahmood SS, Zhang L, et al.
Journal article
Prospective development and validation of a liquid immune profile-based signature (LIPS) to predict response of patients with recurrent/metastatic cancer to immune checkpoint inhibitors (2021)
Zhou J, Donaubauer AJ, Frey B, Becker I, Rutzner S, Eckstein M, Sun R, et al.
Journal article, Review article
Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition (2021)
Rogiers A, Da Silva IP, Tentori C, Tondini CA, Grimes JM, Trager MH, Nahm S, et al.
Journal article
Control of PD-L1 expression in CLL-cells by stromal triggering of the Notch-c-Myc-EZH2 oncogenic signaling axis (2021)
Böttcher M, Bruns H, Völkl S, Lu J, Chartomatsidou E, Papakonstantinou N, Mentz K, et al.
Journal article
Differential effect on different immune subsets of neoadjuvant chemotherapy in patients with TNBC (2020)
Massa C, Karn T, Denkert C, Schneeweiss A, Hanusch C, Blohmer JU, Zahm DM, et al.
Journal article
Radiomics to predict outcomes and abscopal response of patients with cancer treated with immunotherapy combined with radiotherapy using a validated signature of CD8 cells (2020)
Sun R, Sundahl N, Hecht M, Putz F, Lancia A, Rouyar A, Milic M, et al.
Journal article
CAR-T cells and TRUCKs that recognize an EBNA-3C-derived epitope presented on HLA-B∗35 control Epstein-Barr virus-associated lymphoproliferation (2020)
Dragon AC, Zimmermann K, Nerreter T, Sandfort D, Lahrberg J, Kloss S, Kloth C, et al.
Journal article
Immune checkpoint inhibition therapy for advanced skin cancer in patients with concomitant hematological malignancy: a retrospective multicenter DeCOG study of 84 patients (2020)
Leiter U, Loquai C, Reinhardt L, Rafei-Shamsabadi D, Gutzmer R, Kaehler K, Heinzerling L, et al.
Journal article
Safety and efficacy of single cycle induction treatment with cisplatin/docetaxel/ durvalumab/tremelimumab in locally advanced HNSCC: first results of CheckRad-CD8 (2020)
Hecht M, Gostian AO, Eckstein M, Rutzner S, von der Grün J, Illmer T, Hautmann MG, et al.
Journal article
Cytotoxic T-cell-related gene expression signature predicts improved survival in muscle-invasive urothelial bladder cancer patients after radical cystectomy and adjuvant chemotherapy (2020)
Eckstein M, Strissel P, Strick R, Weyerer V, Wirtz R, Pfannstiel C, Wullweber A, et al.
Journal article